Welcome to our dedicated page for Agrify SEC filings (Ticker: AGFY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The AGFY SEC filings page on Stock Titan provides access to regulatory documents for Agrify Corporation, which a later Form 8-K identifies as having changed its name to RYTHM, Inc., with common stock listed on the Nasdaq Capital Market under the symbol RYM. These filings offer detailed insight into the company’s changing business mix, capital structure, and brand-focused strategy in the cannabis and hemp sectors.
Among the documents, Form 8-K reports describe key corporate events. An October 2025 8-K explains that the company, formerly known as Agrify Corporation, is now RYTHM, Inc. and that its legacy extraction business has been reclassified as discontinued operations under Accounting Standard Codification Topic 205-20 for specified historical periods. Another 8-K filed in August 2025 outlines a Purchase Agreement under which the company acquired all equity interests in VCP IP Holdings, LLC from an indirect subsidiary of Green Thumb Industries Inc., noting that VCP’s assets consist primarily of intellectual property rights to brands including RYTHM, Beboe, Dogwalkers, Doctor Solomon’s, &Shine, and Good Green.
The same August 2025 filing also describes a Trademark and Recipe License Agreement granting a Green Thumb subsidiary license rights to use certain intellectual property associated with the acquired brands in exchange for a monthly license fee based on product sales. It further details secured convertible notes issued to a Green Thumb subsidiary and other investors, including maturity, interest terms, conversion features into common stock or pre-funded warrants, and ranking relative to other indebtedness.
Earlier filings and press releases referenced in the filings discuss the company’s historical focus on cultivation and extraction solutions and later transactions such as the sale of its cultivation business and financing arrangements. On Stock Titan, these SEC documents are paired with AI-powered summaries that highlight items such as discontinued operations treatment, brand and IP acquisitions, financing structures, and name and ticker changes, helping readers quickly understand the implications of lengthy filings without replacing the underlying official text.
RYTHM, Inc. reported an insider transaction by its Interim CEO and director on a Form 4 dated 11/19/2025. The filing shows that 17,526 shares of common stock were withheld by the company at a price of $19.19 per share to cover tax withholding on the vesting of restricted stock units held by the executive, which is a non‑open‑market transaction coded as “F.”
After this tax withholding, the reporting person beneficially owns 65,849 shares of RYTHM common stock directly and an additional 420 shares indirectly through a daughter. This reflects routine equity compensation administration rather than a discretionary sale of shares into the market.
RYTHM, Inc. reported third‑quarter 2025 results reflecting its shift to hemp-derived THC brands and licensing. Revenue from continuing operations was $4.043 million, producing gross profit of $1.375 million. Operating loss from continuing operations was $8.888 million, and net loss totaled $10.665 million.
The company completed brand IP deals in 2025, acquiring MC Brands for $5.1 million and VCP brand rights for $50.0 million, expanding the RYTHM, incredibles, Dogwalkers, Beboe, &Shine, Doctor Solomon’s, and Good Green portfolio. Discontinued operations include the prior Extraction and Cultivation businesses, with a $3.534 million gain on the Extraction exit year‑to‑date.
RYTHM ended the quarter with $35.573 million in cash and cash equivalents and reported $61.497 million of intangible assets. Convertible notes and other borrowings totaled scheduled principal of $90.621 million, including $82.0 million related‑party notes. Stockholders’ equity was $11.722 million. The company changed its name and Nasdaq ticker to RYM effective September 2025.
RYTHM, Inc. filed an 8-K stating it furnished a press release announcing financial results for the quarter ended September 30, 2025. The company furnished the release under Item 2.02, and it is attached as Exhibit 99.1.
The company noted this information is not deemed “filed” for purposes of Section 18 of the Exchange Act and is not incorporated by reference unless specifically stated.
RYTHM, Inc. reported an equity award to its Chief Financial Officer on a Form 4. On 11/03/2025, the officer acquired 6,000 shares of Common Stock at $0, recorded as a grant of restricted stock units under the 2022 Omnibus Equity Incentive Plan. Following the transaction, the officer beneficially owned 6,000 shares directly. The RSUs vest in two equal tranches: 50% on March 15, 2027 and 50% on June 15, 2028.
Green Thumb Industries Inc. (GTBIF) and affiliate RSLGH, LLC filed a Form 4 reporting a debt-to-equity move on November 3, 2025. RSLGH converted a November 2024 convertible note into pre-funded warrants.
The conversion covered $10,000,000 of principal plus $175,000 of accrued interest, issuing 3,222,997 pre-funded warrants at a warrant conversion price of $3.157. The warrants are exercisable at $0.001 per share. A 49.99% beneficial ownership limitation applies, and exercise is also subject to stockholder approval under applicable Nasdaq listing rules, to the extent required.
Green Thumb Industries’ indirect subsidiary RSLGH, LLC reported acquiring 141,343 pre-funded warrants of RYTHM, Inc. (RYM) on a Form 4. The warrants carry a $0.001 exercise price and were issued as payment under the Amended and Restated Shared Services Agreement. The share count was calculated using $26.68 per warrant-equivalent. The warrants are subject to a 49.99% beneficial ownership limitation, and exercise is subject to stockholder approval under applicable Nasdaq listing rules, to the extent required.
RYTHM, Inc. has filed a shelf registration statement on Form S-3 to register various securities for potential future offerings, including common stock, preferred stock, debt securities, warrants and units. The prospectus framework describes the types of terms that may apply to each offering: interest rates, maturities, redemption and conversion features, voting and dividend rights, tax considerations and events of default for debt securities.
The filing incorporates audited financial statements of Double or Nothing LLC for years ended
RYTHM, Inc. filed an 8-K reporting that portions of its FY 2024 Management's Discussion and Analysis and Financial Statements and Supplementary Data were revised to reflect the reclassification of the Extraction Business to discontinued operations. The filing also includes auditor consents from GuzmanGray and Marcum LLP and standard Inline XBRL exhibits. The change indicates the company has treated the Extraction Business as a separate discontinued component for reporting purposes, affecting how prior-year results are presented but the filing does not disclose sale terms, cash impacts, or timing.
RYTHM, Inc. had a Schedule 13G filed reporting that Double or Nothing LLC, together with its members Charles Bieler and Joel Gott, may be deemed to beneficially own 211,391 shares of common stock as of September 30, 2025, representing 9.99% of the outstanding class. The filing states the reported position comprises 97,300 shares of common stock and common stock underlying 247,200 pre-funded warrants that are subject to a beneficial ownership limitation preventing exercise above 9.99%. Each Reporting Person reports no sole voting or dispositive power and shared voting and dispositive power of 211,391 shares. The filing includes standard certifications and signatures from the reporting parties.
Rythm, Inc. (RYM) Form 4 shows Benjamin Kovler, serving as Interim CEO and a director, purchased 1,000 shares of Rythm common stock on 09/25/2025 at $37.0843 per share. After the transaction he directly beneficially owns 19,000 shares and indirectly owns 420 shares through his daughter. The filing was signed by an attorney-in-fact on 09/29/2025.
FAQ
What is the current stock price of Agrify (AGFY)?
What is the market cap of Agrify (AGFY)?
